DPYS, MAL and HSPB1 emerge as potential prognostic biomarkers, with HSPB1 in particular validating as an independent prognostic factor of PCa death in the three studies it has been investigated in [86,90,98]. The gene discussed is HSPB1; the disease is posterior cortical atrophy.